The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
Open accessPublished version of a preprint
Abstract
The efficient spread of SARS-CoV-2 resulted in a unique pandemic in modern history. Despite early identification of ACE2 as the receptor for viral spike protein, much remains to be understood about the molecular events behind viral dissemination. We evaluated the contribution of C-type lectin receptors (CLR S ) of antigen-presenting cells, widely present in respiratory mucosa and lung tissue. DC-SIGN, L-SIGN, Langerin and MGL bind to diverse glycans of the spike using multiple interaction areas. Using pseudovirus and cells derived from monocytes or T-lymphocytes, we demonstrate that while virus capture by the CLRs examined does not allow direct cell infection, DC/L-SIGN, among these receptors, promote virus transfer to permissive ACE2 + Vero E6 cells. A glycomimetic compound designed against DC-SIGN, enable inhibition of this process. These data have been then confirmed using authentic SARS-CoV-2 virus and human respiratory cell lines. Thus, we described a mechanism potentiating viral spreading of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281 · cited 1×
“example, the D614G mutation, which increases virulence, has been reported as potentially increasing glycosylation at neighboring asparagine 616 (Brufsky and Lotze, 2020; Jia et al., 2020; Korber et al., 2020).”
BackgroundLetko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707304114 · Cited by 1,073
Virus entry: molecular mechanisms and biomedical applications
Dimitrov, D. S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro817 · Cited by 701
Cytokine storms: understanding COVID-19
Mangalmurti, N., & Hunter, C. A. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.017 · Cited by 698
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Schmidt, F., Weisblum, Y., Muecksch, F., Hoffmann, H.-H., Michailidis, E., Lorenzi, J. C. C., Mendoza, P., Rutkowska, M., Bednarski, E., Gaebler, C., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201181 · Cited by 572
Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors
Park, Y.-J., Walls, A. C., Wang, Z., Sauer, M. M., Li, W., Tortorici, M. A., Bosch, B.-J., DiMaio, F., & Veesler, D. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0334-7 · Cited by 260
Burleigh, L., Lozach, P.-Y., Schiffer, C., Staropoli, I., Pezo, V., Porrot, F., Canque, B., Virelizier, J.-L., Arenzana-Seisdedos, F., & Amara, A. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2949-2957.2006 · Cited by 151
Research works printed but not linked: 81
- TBH Geijtenbeek, 2009, Signalling through C-type lectin receptors: shaping immune responses, Nat Rev Immunol, 9, 465, 10.1038/nri2569 · DOI · Paper page
- O Takeuchi, 2010, Pattern Recognition Receptors and Inflammation, Cell, 140, 805, 10.1016/j.cell.2010.01.022 · DOI · Paper page
- MAWP de Jong, 2010, C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi, Mol Immunol, 47, 1216, 10.1016/j.molimm.2009.12.016 · DOI
- Y van Kooyk, 2003, DC-SIGN: escape mechanism for pathogens, Nat Rev Immunol, 3, 697, 10.1038/nri1182 · DOI · Paper page
- ME Mnich, 2020, C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens, Front Cell Infect Microbiol, 10, 309, 10.3389/fcimb.2020.00309 · DOI
- W Van Breedam, 2014, Bitter-sweet symphony: glycan-lectin interactions in virus biology, FEMS Microbiol Rev, 38, 598, 10.1111/1574-6976.12052 · DOI · Paper page
- SJ van Vliet, 2007, Innate signaling and regulation of Dendritic cell immunity, Curr Opin Immunol, 19, 435, 10.1016/j.coi.2007.05.006 · DOI · Paper page
- SJ van Vliet, 2008, Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses, Immunol Cell Biol, 86, 580, 10.1038/icb.2008.55 · DOI · Paper page
- CP Alvarez, 2002, C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans, J Virol, 76, 6841, 10.1128/JVI.76.13.6841-6844.2002 · DOI · Paper page
- DL Carbaugh, 2019, Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis, J Virol, 93, e00113, 10.1128/JVI.00113-19 · DOI
- TB Geijtenbeek, 2000, DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells, Cell, 100, 587, 10.1016/S0092-8674(00)80694-7 · DOI · Paper page
- F Halary, 2002, Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection, Immunity, 17, 653, 10.1016/S1074-7613(02)00447-8 · DOI · Paper page
- E Navarro-Sanchez, 2003, Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses, EMBO Rep, 4, 723, 10.1038/sj.embor.embor866 · DOI · Paper page
- L de Witte, 2008, Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission, Trends Mol Med, 14, 12, 10.1016/j.molmed.2007.11.001 · DOI
- SA Jeffers, 2004, CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus, Proc Natl Acad Sci, 101, 15748, 10.1073/pnas.0403812101 · DOI · Paper page
- A Marzi, 2004, DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus, J Virol, 78, 12090, 10.1128/JVI.78.21.12090-12095.2004 · DOI · Paper page
- Z-Y Yang, 2004, pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN, J Virol, 78, 5642, 10.1128/JVI.78.11.5642-5650.2004 · DOI · Paper page
- C Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
- P Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 · DOI · Paper page
- E Petersen, 2020, Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics, Lancet Infect Dis, 20, e238, 10.1016/S1473-3099(20)30484-9 · DOI · Paper page
- M Backovic, 2012, Virus entry: old viruses, new receptors, Curr Opin Virol, 11
- Y Watanabe, 2020, Site-specific glycan analysis of the SARS-CoV-2 spike, Science, eabb9983
- Y Watanabe, 2020, Vulnerabilities in coronavirus glycan shields despite extensive glycosylation, Nat Commun, 11, 2688, 10.1038/s41467-020-16567-0 · DOI · Paper page
- L Casalino, 2020, Shielding and Beyond: The Roles of Glycans in SARS-CoV-2 Spike Protein, bioRxiv
- P Zhao, 2020, Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor, bioRxiv
- A Brufsky, 2020, DC/L-SIGNs of hope in the COVID-19 pandemic, J Med Virol, jmv.25980
- Y Jia, 2020, Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity, bioRxiv
- DH Katz, 2020, Proteomic Profiling in Biracial Cohorts Implicates DC-SIGN as a Mediator of Genetic Risk in COVID-19, Infectious Diseases (except HIV/AIDS)
- C Lucas, 2020, Longitudinal immunological analyses reveal inflammatory misfiring in severe COVID-19 patients, Infectious Diseases (except HIV/AIDS)
- M Relloso, DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-, and Anti-Inflammatory Agents, J Immunol., 10
- OC Grant, 2020, Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition, bioRxiv
- M Sikora, 2020, Map of SARS-CoV-2 spike epitopes not shielded by glycans, bioRxiv
- LA Hussain, 1995, Comparative investigation of Langerhans’ cells and potential receptors for HIV in oral, genitourinary and rectal epithelia, Immunology, 85, 475
- G Tabarani, 2009, DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain, J Biol Chem, 284, 21229, 10.1074/jbc.M109.021204 · DOI
- MM Maalej, 2019, The human macrophage galactose-type lectin, MGL, recognizes the outer core of E. coli lipooligosaccharide, ChemBioChem, cbic.201900087, 10.1002/cbic.201900087 · doi:10.1002/cbic.201900087
- M Thépaut, 2009, Structural studies of langerin and Birbeck granule: a macromolecular organization model, Biochemistry, 48, 2684, 10.1021/bi802151w · DOI
- H Feinberg, 2005, Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR, J Biol Chem, 280, 1327, 10.1074/jbc.M409925200 · doi:10.1074/jbc.m409925200
- A Marzi, 2007, Analysis of the Interaction of Ebola Virus Glycoprotein with DC-SIGN (Dendritic Cell–Specific Intercellular Adhesion Molecule 3–Grabbing Nonintegrin) and Its Homologue DC-SIGNR, J Infect Dis, 196, S237, 10.1086/520607 · DOI
- Z Yang, 1998, Distinct Cellular Interactions of Secreted and Transmembrane Ebola Virus Glycoproteins, Science, 279, 1034, 10.1126/science.279.5353.1034 · DOI · Paper page
- S Ordanini, 2015, Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods, Chem Commun Camb Engl, 51, 3816, 10.1039/C4CC09709B · DOI
- A Berzi, 2016, Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants, Sci Rep, 6, 35373, 10.1038/srep35373 · DOI
- V Porkolab, 2020, Development of C-type lectin-oriented surfaces for high avidity glycoconjugates: towards mimicking multivalent interactions on the cell surface, Org Biomol Chem, 18, 4763, 10.1039/D0OB00781A · doi:10.1039/d0ob00781a
- AA Lambert, 2008, The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways, Blood, 112, 1299, 10.1182/blood-2008-01-136473 · DOI · Paper page
- B Lee, 2001, cis Expression of DC-SIGN Allows for More Efficient Entry of Human and Simian Immunodeficiency Viruses via CD4 and a Coreceptor, J Virol, 75, 12028, 10.1128/JVI.75.24.12028-12038.2001 · DOI · Paper page
- P Liu, 2017, Beyond attachment: Roles of DC-SIGN in dengue virus infection, Traffic Cph Den
- Tseligka Cagno, 2019, Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?, HeparanViruses, 11, 596
- M Bermejo-Jambrina, 2018, C-Type Lectin Receptors in Antiviral Immunity and Viral Escape, Front Immunol, 9, 590, 10.3389/fimmu.2018.00590 · DOI · Paper page
- D Perez-Zsolt, 2019, Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry, Nat Microbiol, 4, 1558, 10.1038/s41564-019-0453-2 · DOI
- A Milewska, 2014, Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells, J Virol, 88, 13221, 10.1128/JVI.02078-14 · DOI · Paper page
- MA Tortorici, 2019, Structural basis for human coronavirus attachment to sialic acid receptors, Nat Struct Mol Biol, 26, 481, 10.1038/s41594-019-0233-y · DOI · Paper page
- DP Han, 2007, Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus Entry, J Virol, 81, 12029, 10.1128/JVI.00315-07 · DOI
- F Chiodo, 2020, Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2, Spike Protein to Host Lectins and Lung Microbiota. bioRxiv
- A-J Behrens, 2017, Structural principles controlling HIV envelope glycosylation, Curr Opin Struct Biol, 44, 125, 10.1016/j.sbi.2017.03.008 · DOI
- P Valverde, 2020, Molecular recognition in C-type lectins: the cases of DC-SIGN, Langerin, MGL, and L-sectin, ChemBioChem, cbic.202000238
- H Feinberg, 2001, Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR, Sci N Y NY, 294, 2163, 10.1126/science.1066371 · DOI · Paper page
- A Cambi, 2004, Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells, J Cell Biol, 164, 145, 10.1083/jcb.200306112 · DOI · Paper page
- AW Mesman, 2012, A Prominent Role for DC-SIGN+ Dendritic Cells in Initiation and Dissemination of Measles Virus Infection in Non-Human Primates, PLoS ONE, 7, e49573, 10.1371/journal.pone.0049573 · DOI
- AW Mesman, 2014, Measles Virus Suppresses RIG-I-like Receptor Activation in Dendritic Cells via DC-SIGN-Mediated Inhibition of PP1 Phosphatases, Cell Host Microbe, 16, 31, 10.1016/j.chom.2014.06.008 · DOI
- J-J Liang, 2018, DC-SIGN Binding Contributed by an Extra N-Linked Glycosylation on Japanese Encephalitis Virus Envelope Protein Reduces the Ability of Viral Brain Invasion, Front Cell Infect Microbiol, 8
- EP Go, 2011, Characterization of Glycosylation Profiles of HIV-1 Transmitted/Founder Envelopes by Mass Spectrometry, J Virol, 85, 8270, 10.1128/JVI.05053-11 · DOI
- NF Parrish, 2013, Phenotypic properties of transmitted founder HIV-1, Proc Natl Acad Sci, 110, 6626, 10.1073/pnas.1304288110 · DOI · Paper page
- TW Geisbert, 2003, Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques, Am J Pathol, 163, 2347, 10.1016/S0002-9440(10)63591-2 · DOI · Paper page
- O Martinez, 2012, The role of antigen-presenting cells in filoviral hemorrhagic fever: Gaps in current knowledge, Antiviral Res, 93, 416, 10.1016/j.antiviral.2012.01.011 · DOI
- A Lüdtke, 2017, Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination, Sci Rep, 7, 43776, 10.1038/srep43776 · DOI
- L Tailleux, 2005, DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis, PLoS Med, 2, e381, 10.1371/journal.pmed.0020381 · DOI · Paper page
- A Dominguez-Soto, 2007, The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells, Blood, 109, 5337, 10.1182/blood-2006-09-048058 · DOI
- I Hamming, 2004, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, 203, 631, 10.1002/path.1570 · DOI · Paper page
- R Amraie, 2020, CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells, bioRxiv
- L de Witte, 2007, Langerin is a natural barrier to HIV-1 transmission by Langerhans cells, Nat Med, 13, 367, 10.1038/nm1541 · DOI · Paper page
- L Yang, 2020, COVID-19: immunopathogenesis and Immunotherapeutics, Signal Transduct Target Ther, 5, 128, 10.1038/s41392-020-00243-2 · DOI · Paper page
- M Relloso, 2002, DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory Agents, J Immunol, 168, 2634, 10.4049/jimmunol.168.6.2634 · DOI · Paper page
- D Blanco-Melo, 2020, Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19, Cell, 181, 1036, 10.1016/j.cell.2020.04.026 · DOI · Paper page
- L Angka, 2020, Is innate immunity our best weapon for flattening the curve?, J Clin Invest, 10.1172/JCI140530, 10.1172/JCI140530 · DOI
- S Achilli, 2020, TETRALEC, Artificial Tetrameric Lectins: A Tool to Screen Ligand and Pathogen Interactions, Int J Mol Sci, 19
- E Chabrol, 2012, Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode, PloS One, 7, e50722, 10.1371/journal.pone.0050722 · DOI
- M Maalej, 2019, Human Macrophage Galactose-Type Lectin (MGL) Recognizes the Outer Core of Escherichia coli Lipooligosaccharide, ChemBioChem, 20, 1778, 10.1002/cbic.201900087 · doi:10.1002/cbic.201900087
- JJ Reina, 2008, Docking, synthesis, and NMR studies of mannosyl trisaccharide ligands for DC-SIGN lectin, Org Biomol Chem, 6, 2743, 10.1039/b802144a · doi:10.1039/b802144a
- RC Valentine, 1968, Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli, Biochemistry, 7, 2143, 10.1021/bi00846a017 · DOI · Paper page
- K Zhang, 2016, Gctf: Real-time CTF determination and correction, J Struct Biol, 193, 1, 10.1016/j.jsb.2015.11.003 · DOI · Paper page
- MA Whitt, 2010, Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines, J Virol Methods, 169, 365, 10.1016/j.jviromet.2010.08.006 · DOI · Paper page
- N Varga, 2014, A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus, Biomaterials, 35, 4175, 10.1016/j.biomaterials.2014.01.014 · DOI
Cited by
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
McCallum, M., De Marco, A., Lempp, F. A., Tortorici, M. A., Pinto, D., Walls, A. C., Beltramello, M., Chen, A., Liu, Z., Zatta, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.028 · Cited by 901
Wang, S., Qiu, Z., Hou, Y., Deng, X., Xu, W., Zheng, T., Wu, P., Xie, S., Bian, W., Zhang, C., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00460-y · Cited by 499
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Zhang, Q., Xiang, R., Huo, S., Zhou, Y., Jiang, S., Wang, Q., & Yu, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00653-w · Cited by 339
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Amraei, R., Yin, W., Napoleon, M. A., Suder, E. L., Berrigan, J., Zhao, Q., Olejnik, J., Chandler, K. B., Xia, C., Feldman, J., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01537 · Cited by 337
Whole-genome sequencing reveals host factors underlying critical COVID-19
Kousathanas, A., Pairo-Castineira, E., Rawlik, K., Stuckey, A., Odhams, C. A., Walker, S., Russell, C. D., Malinauskas, T., Wu, Y., Millar, J., et al. (2022) · Nature · doi:10.1038/s41586-022-04576-6 · Cited by 326
Metadata
- Authors
- Thépaut, M., Luczkowiak, J., Vivès, C., Labiod, N., Bally, I., Lasala, F., Grimoire, Y., Fenel, D., Sattin, S., Thielens, N., Schoehn, G., Bernardi, A., Delgado, R., & Fieschi, F.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-05-20
- Volume
- 17
- Issue
- 5
- Pages
- e1009576
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W3163383906
- Cited by
- 200
- References
- 16
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Grenoble Instruct-ERIC centre (ISBG; UMS 3518 CNRS-CEA-UGA-EMBL)
- University Grenoble Alpes graduate school (FRISBI (ANR-10-INBS-05-02) and GRAL and ANR-17-EURE-0003)
- Fondation Recherche Medicale (FEDER and the GIS-Infrastructures Biologie Sante et Agronomie (IBISA))
- Agence Nationale de la Recherche (ANR-15-IDEX-02)
- Instituto de Investigación Carlos III (FIS PI 1801007)
- H2020 European Research Council (731868)
- “la Caixa” Foundation (Project StopEbola)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.